Who backs Abcuro?
20 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| New Enterprise Associates | Venture capital |
| BlackRock | Other |
| Foresite Capital | Venture capital |
| Samsara BioCapital | Venture capital |
| ShangBay Capital | — |
| Redmile Group | PE / buyout |
| Bain Capital Life Sciences | Venture capital |
| Soleus Capital | PE / buyout |
| New Leaf Venture | Venture capital |
| + 10 more investors · a free account shows the complete list | |
The directory is free. Check sizes and activity — the working columns — are Pro.Unlock prospecting columns
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for Abcuro
Create free account
No card required
For fundraisers
Work this list, don’t just read it
These 20 firms already write checks for companies like Abcuro in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.